Bladder Cancer Clinical Trials Database - Free Access to 511 Studies
Access comprehensive clinical trial information for Bladder Cancer through Pure Global AI's free database. This collection includes 511 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 116 trials are actively recruiting participants.
Research for Bladder Cancer is being conducted in United States of America, China, United Kingdom and 7+ other countries. Leading sponsors include Memorial Sloan Kettering Cancer Center and Mansoura University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer
Whole-slide Image and CT Radiomics Based Deep Learning System for Prognostication Prediction in Bladder Cancer
The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy
An Phase III Study, Multicenter，Randomized Controlled Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.
Investigator Grant (IG) 2022 27746
Pre-operative Immuno-Nutrition in Radical Cystectomy
Diagnostic Performance of the Vesical Imaging-Reporting and Data System (VI-RADS) in Detecting Muscle-invasive Bladder Tumour (MIBC) in Clinical Practice: Comparison With Transurethral Resection of Bladder Cancer (TURB) and Evaluation of Diagnostic Accuracy According to Tumour Location
Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC
Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer
Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer
Phase Ib/II Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma
A Study of Pembrolizumab (MK-3475) Plus V940 in Participants With Bladder Cancer Post-Radical Resection (V940-005)
A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial
Antitumor T Cell Responses in Patients With Bladder Cancer
First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours
A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer
Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy
Comparison of Apixaban Versus Enoxaparin
Stress-reducing Intervention in Urothelial Carcinoma
Analyzing the Urine During BCG Instillation in Bladder Cancer Patients for Disease Followup
Pure Global AI provides free access to 511 clinical trials studying Bladder Cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Memorial Sloan Kettering Cancer Center, Mansoura University, M.D. Anderson Cancer Center, among others.